Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+1.83M
-
Total reported value, excl. options
-
$96.4M
-
Value change
-
+$14.6M
-
Number of buys
-
44
-
Number of sells
-
-10
-
Price
-
$7.95
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2018
71 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2018.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 60M outstanding shares and own 20.21% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.09M shares), FMR LLC (1.61M shares), 683 Capital Management, LLC (1M shares), SPHERA FUNDS MANAGEMENT LTD. (847K shares), BlackRock Inc. (781K shares), VANGUARD GROUP INC (754K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (750K shares), MILLENNIUM MANAGEMENT LLC (725K shares), MANGROVE PARTNERS (434K shares), and STATE STREET CORP (237K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.